Injection drug users' perspectives on placing HIV prevention and other clinical services in pharmacy settings
- PMID: 22231488
- PMCID: PMC3324615
- DOI: 10.1007/s11524-011-9651-9
Injection drug users' perspectives on placing HIV prevention and other clinical services in pharmacy settings
Abstract
In their role as a source of sterile syringes, pharmacies are ideally situated to provide additional services to injection drug users (IDUs). Expanding pharmacy services to IDUs may address the low utilization rates of healthcare services among this population. This qualitative study of active IDUs in San Francisco explored perspectives on proposed health services and interventions offered in pharmacy settings, as well as facilitators and barriers to service delivery. Eleven active IDUs participated in one-on-one semistructured interviews at a community field site and at a local syringe exchange site between February and May 2010. Results revealed that most had reservations about expanding services to pharmacy settings, with reasons ranging from concerns about anonymity to feeling that San Francisco already offers the proposed services in other venues. Of the proposed health services, this group of IDUs prioritized syringe access and disposal, clinical testing and vaccinations, and provision of methadone. Pharmacists' and pharmacy staff's attitudes were identified as a major barrier to IDUs' comfort with accessing services. The findings suggest that although IDUs would like to see some additional services offered within pharmacy settings, this is contingent upon pharmacists and their staff receiving professional development trainings that cultivate sensitivity towards the needs and experiences of IDUs.
Similar articles
-
Access to syringes for HIV prevention for injection drug users in St. Petersburg, Russia: syringe purchase test study.BMC Public Health. 2013 Mar 1;13:183. doi: 10.1186/1471-2458-13-183. BMC Public Health. 2013. PMID: 23452390 Free PMC article.
-
Barriers to Access to Sterile Syringes as Perceived by Pharmacists and Injecting Drug Users: Implications for Harm Reduction in Lebanon.Subst Use Misuse. 2017 Sep 19;52(11):1420-1428. doi: 10.1080/10826084.2017.1284235. Epub 2017 Apr 21. Subst Use Misuse. 2017. PMID: 28430013
-
Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI.J Urban Health. 2010 Dec;87(6):942-53. doi: 10.1007/s11524-010-9503-z. J Urban Health. 2010. PMID: 21116724 Free PMC article.
-
Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.Int J Drug Policy. 2007 Oct;18(5):417-25. doi: 10.1016/j.drugpo.2007.01.013. Epub 2007 Feb 20. Int J Drug Policy. 2007. PMID: 17854731 Review.
-
The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings.Int J Drug Policy. 2008 Dec;19(6):436-41. doi: 10.1016/j.drugpo.2007.07.006. Epub 2007 Sep 4. Int J Drug Policy. 2008. PMID: 17766100 Review.
Cited by
-
Pharmacy-randomized intervention delivering HIV prevention services during the syringe sale to people who inject drugs in New York City.Drug Alcohol Depend. 2015 Aug 1;153:72-7. doi: 10.1016/j.drugalcdep.2015.06.006. Epub 2015 Jun 10. Drug Alcohol Depend. 2015. PMID: 26118831 Free PMC article. Clinical Trial.
-
Achieving pharmacy-based public health: a call for public health engagement.Public Health Rep. 2013 May-Jun;128(3):140-3. doi: 10.1177/003335491312800303. Public Health Rep. 2013. PMID: 23633728 Free PMC article. No abstract available.
-
I could take the judgment if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018.Harm Reduct J. 2019 Sep 18;16(1):57. doi: 10.1186/s12954-019-0327-1. Harm Reduct J. 2019. PMID: 31533730 Free PMC article.
-
Feasibility of providing interventions for injection drug users in pharmacy settings: a case study among San Francisco pharmacists.J Psychoactive Drugs. 2014 Jul-Aug;46(3):226-32. doi: 10.1080/02791072.2014.921745. J Psychoactive Drugs. 2014. PMID: 25052881 Free PMC article.
-
Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015.J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S34-S44. doi: 10.1016/j.japh.2016.12.077. Epub 2017 Feb 8. J Am Pharm Assoc (2003). 2017. PMID: 28189540 Free PMC article.
References
-
- Normand J, Vlahov D, Moses L. Preventing HIV transmission: the role of sterile needles and bleach. Washington, DC: National Academy of Medicine; 1995. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical